Keywords: expanded, label, gsk, hycamtin, uk, drug, major

Expanded US label for GSK's Hycamtin

Article | 26 June 2006

Print This

UK drug major GlaxoSmithKline says that the US Food and Drug Administration has approved its topoisomerase I inhibitor Hycamtin (topotecan) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in